Product Strategy: Make the Choice Behind the Roadmap

A product team has three plausible requests. Sales wants an enterprise reporting feature. Support wants a shorter setup process. An existing customer wants another integration. Each request has an advocate, an estimated cost and a place on the roadmap. Nobody can explain which customer problem the product intends to solve first.

Putting dates beside the requests leaves that question unanswered. Product strategy needs a choice that affects how the team spends its limited capacity. Someone should be able to explain the intended customer, the problem worth concentrating on, the alternative being deferred and the evidence that could change the decision.

Consider a fictional workflow product used by small professional-services firms. Its team is investigating why some new accounts stop using the product before completing a first client handover. There are no customer results behind this example. It is a way to examine how a team might choose among competing explanations and investments.

Separate the observed problem from the preferred feature

The observation is that some new accounts do not complete a first useful handover. "We need more integrations" is one possible explanation. Others include unclear responsibilities, missing client information or a customer segment whose process the product does not support.

Begin with a case record. For an account that stopped, identify the intended task, where progress ended and what the person did next. Compare that account with one that completed the task. Ask whether the apparent failure belongs to the product, the customer's process or the measure being used. An administrator who creates an account may be a different person from the colleague expected to complete the handover.

Keep contradictory cases. A firm that succeeds with a spreadsheet import weakens the claim that an integration is always necessary. A firm that imports its data but cannot assign responsibility points to another problem. The research-synthesis guide explains how to retain these differences while deciding what to investigate.

At this stage, the diagnosis should state both its evidence and its uncertainty. It might read: "We suspect that small teams lose momentum when nobody owns the first handover. We have not yet established whether setup guidance or a missing system connection is the larger obstacle." That is a research position, not a reason to announce a finished strategy.

Make a choice about the next commitment

Roman Pichler's May 2026 product-strategy framework connects choices about customers, needs, distinctive features and business goals with the roadmap and backlog. It also allows evidence from execution to change the strategy. This is his practitioner framework, not a universal sequence or proof of a particular result. Pichler's revised framework

For the workflow product, a proposed direction could be: help small firms complete their first client handover with an explicitly assigned owner before investing in broad enterprise reporting. The distinction from the product's vision and non-goals is the commitment. The vision may describe the long-term purpose; this choice identifies where the team will investigate and spend next.

The tradeoff should survive a difficult request. If enterprise reporting becomes urgent for a major prospect, record what accepting it would displace. The product lead may decide to change direction. That decision should include the commercial consequence, delivery capacity and evidence, rather than allowing an exception to rewrite the strategy without a record.

The table does not rank these options. It makes the disagreement specific enough to examine. An integration and guided setup might eventually belong together, but funding both immediately would hide which explanation the team is testing.

Connect a funded bet to an observable outcome

A bet needs more than a feature name. Record who it is for, the behavior expected to change, the evidence supporting that expectation and the person responsible for the decision. Define what would cause the team to expand, revise or stop the approach.

For guided setup, an early test could ask a participant to complete a handover using their own realistic information. Observe where help is required and whether the next person can act on the result. A completed walkthrough with a researcher supplying missing information does not establish independent use. The team should record the assistance rather than counting the session as an unqualified success.

A later product measure could examine completion among eligible new accounts. Specify the cohort, observation window and task definition before reviewing results. Track failures as well: a higher completion count is unhelpful if people assign the wrong owner or send incomplete work to a client. Treat any proposed threshold as a decision rule agreed for this product, not an industry benchmark.

The UK Government Service Manual recommends establishing a baseline and testing risky assumptions while exploring options. Its guidance is written for government services; the measurement suggestions here are an editorial application to a fictional commercial product. Measuring service benefits

Give new evidence a route back into the decision

Leave the meeting with a decision someone else can reconstruct

Save the rejected alternatives alongside the chosen direction. For each deferral, distinguish a deliberate tradeoff from a prerequisite that still has to be delivered. A security requirement cannot be treated as an optional competing feature simply because it does not improve the activation measure.

Keep the previous strategy version when evidence changes. Record the observation that changed the decision, who accepted the consequence and which roadmap commitments need revision. Sales and support need an explanation they can use with customers; they should not have to infer a new direction from a reordered backlog.

For this fictional team, the immediate output may be a small guided-handover experiment and a deferred reporting proposal. The larger product investment remains conditional. A strategy review has done useful work when the team can explain that commitment, its cost to the alternatives and the evidence needed for the next decision.